# WELL Health Technologies Corp. (WELL.TO) fundamentals

Data as of 2026-09-08. TSX, Canada. Sector: Healthcare / Health Care Equipment & Supplies. Price C$4.25, market value C$1.1 billion.

## Valuation
- **P/E (trailing): 212.5×** (5-yr avg 4306.3×, 3-yr avg 6443.1×). WELL Health Technologies Corp. trades at 212.5× trailing earnings, well below its own five-year average of 4306.3×: cheap by its own standards. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 11.5×, lower than trailing, so analysts expect earnings to grow.
- **Price / sales: 0.7×**. Each dollar of revenue is priced at 0.7×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 1.3×**. The shares trade at 1.3× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 8.0×**. Enterprise value is 8.0× operating earnings before depreciation, the multiple that ignores how the company is financed; below 8× is inexpensive for most sectors.
- **Free-cash-flow yield: 7.8%** (5-yr avg 3.7%). Free cash flow equals 7.8% of the market value, above its five-year average of 3.7%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.
- **Earnings yield: 0.5%**. The inverse of the P/E: 0.5% of the price is earned each year.

## Profitability
- **Gross margin: 37.2%**. WELL Health Technologies Corp. keeps 37.2% of revenue after the direct cost of what it sells.
- **Operating margin: 6.9%**. 6.9% of revenue is left after running the business.
- **Net margin: -3.6%**. The company reported a net loss over the last twelve months.
- **Return on equity: -5.8%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: 6.3%**. Return on all capital, debt included, is 6.3%.
- **Return on assets: 0.2%**. Each dollar of assets produces 0.2% of profit.

## Growth
- **Revenue growth (1 yr): 52.2%** (3-yr 35.0%/yr, 5-yr 94.5%/yr). Revenue grew 52.2% over the last year, against 94.5% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): -122.4%**. Earnings per share fell 122.4%, slower than revenue, so margins compressed.
- **Free-cash-flow growth (3 yr): 7.8%/yr**. Free cash flow has compounded at 7.8% a year over three years.

## Financial health
- **Debt to equity: 0.82**. Debt is 0.82 times equity, moderate leverage.
- **Net debt / EBITDA: 2.8×**. It would take 2.8 years of operating earnings to repay net borrowings, within the comfortable range.
- **Interest coverage: 1.4×**. Operating profit covers interest only 1.4×: fragile.
- **Current ratio: 1.03** (quick 1.03). Current assets cover the next year's liabilities 1.03 times.
- **Altman Z-score: 2.05**. A Z-score of 2.05 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. WELL Health Technologies Corp. does not currently pay a dividend, but it returned 0.3% of its market value through buybacks over the last year.

## Price and momentum
- **Total return (1 yr): -9.0%** (YTD 6.5%, 3-mo -12.2%). The shares are down 9.0% over twelve months including dividends.
- **From 52-week high: -30.1%** (18.7% above the low). Trading 30% below its 52-week high, deep in a drawdown.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 48**. An RSI of 48 is neutral.
- **Beta (1 yr): 1.16** (volatility 40%). Beta of 1.16 against the S&P/TSX Composite: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=WELL.TO · Page: https://foliofundamentals.com/stocks/well.to

Not investment advice.